鞣花酸及其肠道代谢产物在大肠癌中的研究进展

doi:10.11904/j.issn.1002-3070.2016.03.014

摘要/Abstract

摘要： 大肠癌(Colorectal cancer)是胃肠道疾病中常见的恶性肿瘤,其发病率及死亡率日益增高。近年来,植物化学提取物在大肠癌的化学预防及治疗方面所起到的作用已经受到广泛关注。随着研究的进展,植物化学提取物的研究已经从水果等粗提取混合物向化学单体成分转变。研究发现鞣花酸及其肠道代谢产物作为石榴、树莓等水果中的活性单体成分具有预防及抑制大肠癌的作用,作用机制主要与抑制肿瘤细胞增殖、促进肿瘤细胞凋亡、阻断细胞周期、抑制肿瘤血管形成、逆转耐药和增强化疗药物氟尿嘧啶敏感性等途径密切相关。本文主要就鞣花酸及其肠道代谢产物在预防和治疗大肠癌方面的最新研究进展进行综述。

关键词: 鞣花酸, 肠道代谢产物, 大肠癌

Abstract: Colorectal cancer is a common gastrointestinal malignant disease.Its incidence and mortality rates are elevated.In recent years,chemical plant extracts has attracted considerable attention in the chemical prevention and treatment of colorectal cancer.Studies found that ellagic acid and its gut microbiota metabolite have the effect on colorectal cancer.The mechanisms are closely related to promoting tumor cell apoptosis and inhibiting tumor cell proliferation,blocking the cell cycle,inhibiting tumor angiogenesis,reversing resistance and enhancing the sensitivity of chemotherapy drug.In this paper,the latest research progress and the mechanisms of the ellagic acid and its gut microbiota metabolite on the prevention and treatment of colorectal cancer are reviewed.

Key words: Ellagic acid, Gut microbiota metabolite, Colorectal cancer

中图分类号:

R735.3

张津宁, 李国东, 陈洪生综述, 刘明校审. 鞣花酸及其肠道代谢产物在大肠癌中的研究进展[J]. 实用肿瘤学杂志, 2016, 30(3): 262-265.

ZHANG Jinning,LI Guodong,CHEN Hongsheng,LIU Ming. Research progress of the effect and mechanisms of ellagic acid and its gut microbiota metabolite on colorectal cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(3): 262-265.

参考文献

1 Siegel RL,Miller KD,Jemal A.Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
2 Siegel RL,Ma J,Zou Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29.
3 刘明.结直肠癌多酚类植物化学预防剂的研究进展[J].中华结直肠疾病电子杂志,2014,3(5):8-11.
4 冯立娟,陶吉寒,尹燕雷,等.石榴功能物质鞣花酸研究进展[J].食品科学,2014,35(23):325-330.
5 Bala I,Bhardwaj V,Hariharan S,et al.Analytical methods for assay of ellagic acid and its solubility studies[J].J Pharm Biomed Anal,2006,40(1):206-210.
6 Nunez-Sanchez MA,Garcia-Villalba R,Monedero-Saiz T,et al.Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma,urine and colon tissues from colorectal cancer patients[J].Mol Nutr Food Res,2014,58(6):1199-1211.
7 Gonzalez-Sarrias A,Gimenez-Bastida JA,Nunez-Sanchez MA,et al.Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells[J].Eur J Nutr,2014,53(3):853-864.
8 Kasimsetty SG,Bialonska D,Reddy MK,et al.Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins[J].J Agric Food Chem,2010,58(4):2180-2187.
9 Gonzalez-Barrio R,Borges G,Mullen W,et al.Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy[J].J Agric Food Chem,2010,58(7):3933-3939.
10 Umesalma S,Nagendraprabhu P,Sudhandiran G.Ellagic acid inhibits proliferation and induced apoptosis via the Akt signaling pathway in HCT-15 colon adenocarcinoma cells[J].Mol Cell Biochem,2015,399(1-2):303-313.
11 Cho H,Jung H,Lee H,et al.Chemopreventive activity of ellagitannins and their derivatives from black raspberry seeds on HT-29 colon cancer cells[J].Food Funct,2015,6(5):1675-1683.
12 Larrosa M,Tomas-Barberan FA,Espin JC.The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway[J].J Nutr Biochem,2006,17(9):611-625.
13 Malik A,Afaq S,Shahid M,et al.Influence of ellagic acid on prostate cancer cell proliferation:a caspase-dependent pathway[J].Asian Pac J Trop Med,2011,4(7):550-555.
14 邢晓平,杨笑笑,卢婕,等.石榴皮中鞣花酸的抗衰老性能及机理研究[J].食品与生物技术学报,2015,34(4):436-442.
15 Spencer WA,Jeyabalan J,Kichambre S,et al.Oxidatively generated DNA damage after Cu(II)catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins:Role of reactive oxygen species[J].Free Radic Biol Med,2011,50(1):139-147.
16 Bialonska D,Kasimsetty SG,Khan SI,et al.Urolithins,intestinal microbial metabolites of pomegranate ellagitannins,exhibit potent antioxidant activity in a cell-based assay[J].J Agric Food Chem,2009,57(21):10181-10186.
17 Kallio T,Kallio J,Jaakkola M,et al.Urolithins display both antioxidant and pro-oxidant activities depending on assay system and conditions[J].J Agric Food Chem,2013,61(45):10720-10729.
18 Seeram NP,Adams LS,Henning SM,et al.In vitro antiproliferative,apoptotic and antioxidant activities of punicalagin,ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice[J].J Nutr Biochem,2005,16(6):360-367.
19 Adams LS,Seeram NP,Aggarwal BB,et al.Pomegranate juice,total pomegranate ellagitannins,and punicalagin suppress inflammatory cell signaling in colon cancer cells[J].J Agric Food Chem,2006,54(3):980-985.
20 Petiot A,Ogier-Denis E,Blommaart EF,et al.Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells[J].J Biol Chem,2000,275(2):992-998.
21 Gonzalez-Sarrias A,Larrosa M,Tomas-Barberan FA,et al.NF-kappaB-dependent anti-inflammatory activity of urolithins,gut microbiota ellagic acid-derived metabolites,in human colonic fibroblasts[J].Br J Nutr,2010,104(4):503-512.
22 Rosillo MA,Sanchez-Hidalgo M,Cardeno A,et al.Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats[J].Pharmacol Res,2012,66(3):235-242.
23 Marin M,Maria Giner R,Rios JL,et al.Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis[J].J Ethnopharmacol,2013,150(3):925-934.
24 Huang ST,Yang RC,Wu HT,et al.Zinc-chelation contributes to the anti-angiogenic effect of ellagic acid on inhibiting MMP-2 activity,cell migration and tube formation[J].PLoS One,2011,6(5):e18986.
25 Haraguchi T,Kayashima T,Okazaki Y,et al.Cecal succinate elevated by some dietary polyphenols may inhibit colon cancer cell proliferation and angiogenesis[J].J Agric Food Chem,2014,62(24):5589-5594.
26 Ramirez de Molina A,Vargas T,Molina S,et al.The ellagic acid derivative 4,4′-di-O-methylellagic acid efficiently inhibits colon cancer cell growth through a mechanism involving WNT16[J].J Pharmacol Exp Ther,2015,353(2):433-444.
27 Gonzalez-Sarrias A,Tome-Carneiro J,Bellesia A,et al.The ellagic acid-derived gut microbiota metabolite,urolithin A,potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells[J].Food Funct,2015,6(5):1460-1469.

[1]	吕强, 陈洪生, 李国东, 魏九峰(综述), 刘明(审校). 肿瘤相关成纤维细胞在大肠癌发生发展中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(3): 275-279.
[2]	段佩雯, 赵苗苗综述, 王松坡审校. NF-κB对大肠癌发生发展的影响及其相关治疗的研究现状[J]. 实用肿瘤学杂志, 2017, 31(1): 43-47.
[3]	吴杨佳子,鹿晓麟,赵琦,高玉艳,张艳桥. Arg-1在大肠炎症相关性肿瘤中的表达及意义[J]. 实用肿瘤学杂志, 2016, 30(4): 339-345.
[4]	王倩, 陈铁龙, 王彩芹, 罗微. 大肠癌中CD133、COX-2的表达及DNA倍体的研究[J]. 实用肿瘤学杂志, 2016, 30(3): 200-206.
[5]	黄卫东, 于洪娟, 郑二维, 贺长志, 赵晓雯综述, 刘国祥校审. 大肠癌筛查经济学评价研究进展[J]. 实用肿瘤学杂志, 2015, 29(5): 462-466.
[6]	宫晨,周军德,迟强,崔滨滨,赵亚双,王帆. CYP24A1基因多态性与大肠癌发生及预后的关系[J]. 实用肿瘤学杂志, 2015, 29(4): 289-293.
[7]	方东, 王志红. 中性粒细胞/淋巴细胞比值在大肠癌癌变进展中的指示价值[J]. 实用肿瘤学杂志, 2015, 29(1): 44-48.
[8]	崔滨滨, 刘彦龙, 陈洪生, 周飞, 于雪峰, 徐海涛. 抑癌基因ING3在大肠癌中表达及意义[J]. 实用肿瘤学杂志, 2014, 28(6): 481-484.
[9]	薛伟男,张干,杨艳梅,马玉彦,孙根,崔滨滨. 抑癌基因ING1在大肠癌中的表达及预后意义[J]. 实用肿瘤学杂志, 2014, 28(5): 385-390.
[10]	李丹丹, 胡付兰, 朱琳, 王彝白娜, 刘宇鹏, 陈王洋, 崔滨滨, 赵亚双. 心理社会危险因素与大肠癌的相关性研究[J]. 实用肿瘤学杂志, 2012, 26(4): 328-335.
[11]	李爽, 陈元. Mina53、Ki-67在中国人大肠癌中的表达及其与临床病理学之间的关系[J]. 实用肿瘤学杂志, 2011, 25(6): 537-543.
[12]	白玉贤, 刘磊, 隋红, 魏孝礼, 苑珩珩. 利用RNA干扰技术分析Pokemon对Lovo增殖过程的影响[J]. 实用肿瘤学杂志, 2011, 25(5): 406-410.
[13]	朱志兵, 文剑锋, 何丽娟, 郑凯, 徐敏. 大肠癌患者结肠造口并发症的治疗及预防[J]. 实用肿瘤学杂志, 2010, 24(3): 217-219.
[14]	林晶, 耿敬姝, 于晓宇, 张大川, 曾广春. Ezrin蛋白与大肠癌上皮间质转化及侵袭转移的关系[J]. 实用肿瘤学杂志, 2010, 24(1): 33-37.
[15]	孙琦, 刘瑞宝, 杨奕. MSCT三维重建在结、直肠癌定量诊断及术前分期中的应用价值[J]. 实用肿瘤学杂志, 2010, 24(1): 70-73.